Ignite Creation Date:
2024-10-25 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06516510
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-06-17
Brief Title:
A Dosimetry Study of Lutetium 177Lu rhPSMA-101 and Lutetium 177Lu Vipivotide Tetraxetan Pluvicto in Patients With Non-curative Metastatic Prostate Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomised Multi-centre Intra-patient Imaging and Dosimetry Crossover Study of Lutetium 177Lu rhPSMA-101 and Lutetium 177Lu Vipivotide Tetraxetan Pluvicto in Patients With Non-curative Metastatic Prostate Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A randomised multi-centre intra-patient imaging and dosimetry crossover study of lutetium 177Lu rhPSMA 101 and lutetium 177Lu vipivotide tetraxetan Pluvicto in patients with non-curative metastatic prostate cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None